North America’s medical devices industry saw a drop of 32.99% in deal activity during October 2021, when compared with the last 12-month average, led by Boston Scientific’s $1.75bn acquisition of Baylis MedicalInc, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 65 medical devices industry deals worth $4.7bn were announced for the region in October 2021, against the 12-month average of 97 deals.

Of all the deal types, venture financing saw most activity in October 2021 with 46 transactions, representing a 70.8% share for the region.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In second place was M&A with 16 deals, followed by private equity deals with three transactions, respectively capturing a 24.6% and 4.6% share of the overall deal activity for the month.

In terms of value of deals, M&A was the leading category in North America’s medical devices industry with $2.72bn, while venture financing and private equity deals totalled $1.92bn and $20m, respectively.

North America medical devices industry deals in October 2021: Top deals

The top five medical devices deals accounted for 70.3% of the overall value during October 2021.

The combined value of the top five medical devices deals stood at $3.27bn, against the overall value of $4.7bn recorded for the month.

The top five medical devices industry deals of October 2021 tracked by GlobalData were:

1) Boston Scientific $1.75bn acquisition deal with Baylis MedicalInc

2) The $600m venture financing of Hinge Health by Alkeon Capital,Coatue Management,Tiger Global and Whale Rock Capital Management

3) 3D Systems $400m acquisition deal with Volumetric

4) The $304m venture financing of Medable by Blackstone,GSR Ventures,Sapphire Ventures,Tiger Global Management and Western Technology Investment

5) Integer $220m acquisition deal with Oscor